News
Pathological gambling is associated with age
Researchers of the Psychiatry and Mental Health research group at the Bellvitge Biomedical Research Institute (IDIBELL), in the Bellvitge University Hospital, have shown that patient age influences the onset of pathological gambling disorder and its clinical course. The study results were published in the Journal of Gambling Studies. Personality traits The study was conducted with […]
Kevin M. Ryan: “The goal of a science basic lab should be transfer knowledge to therapeutic improvements for patients”
Cell death is the field of study of the researcher Kevin M. Ryan at The Beatson Institute for Cancer Research in Glasgow (UK). On Friday, March 22 within the cycle of seminars IDIBELL, Ryan explained the latest advances in his research of one of the mechanisms of cell death: autophagy. The goal of the laboratory […]
IDIBELL and VHIR licenses Histocell a patent for acute respiratory diseases with stem cells
The Bellvitge Biomedical Research Institute (IDIBELL) has signed a licensing agreement with the Spanish biotech company Histocell to make use of a patent for the treatment of acute pulmonary diseases with mesenchymal stem cells. These cells, administered intravenously, have the ability to go directly to the damaged lungs, acting as a “smart drug”. To enhance […]
Endoscopy treatments save hospital admissions
Advances in therapeutic endoscopy techniques, with the development of a score of innovative procedures are enabling increasingly performing digestive disorders interventions without resorting to conventional surgery with hospitalization. “Digestive endoscopy is less invasive than conventional surgical techniques as it is done by inserting a tube with a camera through the mouth. Such treatments are gaining […]
Ángel Carracedo: ”Only 50% of first-line drugs are effective”
The Professor of Legal Medicine and director of the Genomic Medicine lab at the University of Santiago de Compostela, Angel Carracedo, talked of the future challenges of the field of pharmacogenetics in the clinic. It was last March 15 at a conference within the framework of the IDIBELL seminars. Currently only 50% of first-line drugs […]
Discovered the epigenetic mechanism through which protein SirT2 regulates cell cycle progression and genomic stability
The study of IDIBELL researchers confirms antitumor properties of sirtuin 2 Clinical applications of SIRT2 Control of epigenetic marks Article’s reference The Tumor supressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation.
Experts from around the world participate in the XIII International Gynecological Surgery Course of the Bellvitge University Hospital
According to the director of the course, Jordi Ponce, “for this edition, we have proposed as monographic topics endometrial cancer of all types and routes of surgical approach, from simple vaginal hysterectomy to the most complex robotic staging, the surgical treatment of uterine myoma with hysteroscopic approach, laparoscopic, robotics or laparotomy, and, finally, the meshes […]
Found in Amish a genetic mutation causing mental retardation very similar to Angelman syndrome
Researchers from the research group in growth factors and cell differentiation at IDIBELL and the University of Barcelona (UB) have participated in an international study that has identified the genetic cause of developmental delay observed in Amish individuals in the USA. The research results have been published in the Journal of Medical Genetics. Amish community […]
Discovered the anti-inflammatory and immunoregulatory potential of a protein involved in the combat system against pathogens
Researchers in the research group of human molecular genetics of the IDIBELL have found that an isoform (variant) of the protein C4BP provides antiinflammatory and immunoregulatory characteristics to dendritic cells, which are essential to our immune system. This molecule could be useful in treatments to combat transplant rejection and to find new therapies against autoimmune […]